Last update 19 Apr 2025

Human hepatitis B immunoglobulin(Cangene Europe Limited))

Overview

Basic Info

Drug Type
Immunoglobulin
Synonyms
ImmunoGam
Target
L-HBsAg
Action
inhibitors, modulators
Mechanism
L-HBsAg inhibitors(L-HBsAg inhibitors), Immunomodulators
Therapeutic Areas
Infectious DiseasesDigestive System Disorders
Active Indication-
Inactive Indication
Hepatitis B
Originator Organization
Cangene Corp.Cangene Corp.
Active Organization-
Inactive Organization
Aptevo Europe Ltd.
Drug Highest PhaseWithdrawn
First Approval Date
European Union (16 Mar 2010),
Hepatitis B
Regulation-
Login to view timeline

Related

100 Clinical Results associated with Human hepatitis B immunoglobulin(Cangene Europe Limited))
Login to view more data
100 Translational Medicine associated with Human hepatitis B immunoglobulin(Cangene Europe Limited))
Login to view more data
100 Patents (Medical) associated with Human hepatitis B immunoglobulin(Cangene Europe Limited))
Login to view more data
100 Deals associated with Human hepatitis B immunoglobulin(Cangene Europe Limited))
Login to view more data

External Link

KEGGWikiATCDrug Bank
--
J06BB04
-

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hepatitis B
European Union
Aptevo Europe Ltd.
16 Mar 2010
Hepatitis B
Iceland
Aptevo Europe Ltd.
16 Mar 2010
Hepatitis B
Liechtenstein
Aptevo Europe Ltd.
16 Mar 2010
Hepatitis B
Norway
Aptevo Europe Ltd.
16 Mar 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free